IMARC Group's report titled " Image-guided Therapy Systems Market Report by Product (Ultrasound Systems, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET), Endoscopes, Magnetic Resonance Imaging (MRI), X-ray Fluoroscopy, and Others), Application (Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers, Research and Academic Institutions, and Others), and Region 2024-2032", The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample

Factors Affecting the Growth of the Image-guided Therapy Systems Industry:

• Technological Advancements:

Innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and X-ray, are leading to the development of more advanced image-guided therapy systems. These advancements enable higher-resolution imaging, real-time monitoring, and improved accuracy in treatment delivery. Image-guided therapy systems are becoming more precise, efficient, and versatile, expanding their applications across various medical specialties. Clinicians benefit from enhanced visualization capabilities, allowing for more accurate diagnosis, treatment planning, and intervention. Patients also benefit from reduced procedure times and improved outcomes.

• Increasing Prevalence of Chronic Diseases:

The growing demand for image-guided therapy systems on account of the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, among the masses around the world is offering a positive market outlook. These conditions require complex and precise treatment interventions. In addition, image-guided procedures offer minimally invasive (MI) alternatives to traditional surgeries, providing patients with less discomfort, shorter recovery times, and improved quality of life. The increasing need for advanced technologies that can provide real-time imaging guidance during surgeries and other interventions is strengthening the market growth.

• Rising Focus on MI Procedures:

The escalating demand for image-guided therapy systems due to increasing preferences for MI procedures over traditional surgeries is supporting the market growth. MI procedures offer various benefits, such as reduced postoperative pain and shorter hospital stays. Image-guided therapy systems play a crucial role in facilitating MI interventions by providing real-time imaging guidance to clinicians during procedures. These systems enable precise navigation and targeted delivery of therapies, enhancing treatment outcomes while minimizing risks to patients. Furthermore, healthcare providers and patients are becoming aware about the importance of advanced imaging technologies in modern healthcare delivery.

Leading Companies Operating in the Global Image-guided Therapy Systems Industry:

• Analogic Corporation
• Brainlab AG
• FUJIFILM Holdings Corporation
• General Electric Company
• Karl Storz SE & Co. KG
• Koninklijke Philips N.V.
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation
• Varian Medical Systems Inc.

Image-guided Therapy Systems Market Report Segmentation:

By Product:

• Ultrasound Systems
• Computed Tomography (CT) Scanners
• Positron Emission Tomography (PET)
• Endoscopes
• Magnetic Resonance Imaging (MRI)
• X-ray Fluoroscopy
• Others

Endoscopes represent the largest segment as they enable direct visualization of internal organs and structures without the need for open surgery.

By Application:

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Oncology Surgery
• Gastroenterology
• Others

Cardiac surgery holds the biggest market share on account of the increasing incidence of cardiovascular diseases among individuals.   

By End Use: 

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Research and Academic Institutions
• Others
   

Hospitals and clinics account for the largest market share due to the rising focus on enhanced patient care.  

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the image-guided therapy systems market, which can be attributed to the presence of highly developed healthcare infrastructure with advanced medical facilities.   

Global Image-guided Therapy Systems Market Trends:

The increasing employment of image-guided therapy systems among the geriatric population is impelling the market growth. Older adults are more susceptible to age-related health conditions that require advanced medical interventions. The growing prevalence of degenerative conditions and age-related injuries is offering a positive market outlook. These systems play a critical role in diagnosing age-related conditions, guiding treatment decisions, and monitoring disease progression in elderly patients. Additionally, older adults are preferring less invasive treatment options that offer quick recovery times and fewer complications.

The rising focus on personalized treatment approaches tailored as per individual patient characteristics is bolstering the market growth.  

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163